Corcept Therapeutics CORT Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's share buybacks?
- Corcept Therapeutics (CORT) reported share buybacks of $0 in Q1 2026.
- How has Corcept Therapeutics's share buybacks changed year-over-year?
- Corcept Therapeutics's share buybacks decreased by 100.0% year-over-year, from $27.43M to $0.
- What does share buybacks mean?
- Cash spent by the company to buy back its own shares from the market.
- How do you interpret share buybacks?
- An increase indicates a focus on returning capital to shareholders or offsetting dilution, while a decrease may suggest capital preservation or reinvestment in growth.
- How does share buybacks compare across companies?
- Commonly reported by mature companies with strong cash flow; peers often disclose this in the financing section of the cash flow statement.